Illumina Collaborates to Assess In-House Comprehensive Cancer Genomic Profiling
Illumina and Allegheny Health Network will collaborate to evaluate the impact of in-house comprehensive genomic profiling for patient care.
Illumina and Allegheny Health Network will collaborate to evaluate the impact of in-house comprehensive genomic profiling for patient care.
A recent study confirmed that scent detection dogs can be taught to identify individuals with a coronavirus infection from skin swabs.
Laboratory leadership needs to develop coherent succession planning to allow for the continuity of laboratory operations.
Illumina and Allegheny Health Network will collaborate to evaluate the impact of in-house comprehensive genomic profiling for patient care.
Alamar and Mologic are collaborating to utilize Alamar's novel antibodies against SARS-CoV-2 Nucleocapsid protein for future COVID tests.
The system automates tasks such as serial dilutions, sample normalization, hit picking or pipetting of complex plate layouts.
People suffering from long COVID may face an increased risk of abnormal blood clotting, according to a study published in Blood Advances.
A team of researchers is working toward a new detection method for ovarian cancer, which uses machine learning techniques.
Molecular Devices launched its SpectraMax Mini Multi-Mode Microplate Reader, aimed to save researchers benchtop space and budget.
Verichem Laboratories now offers completely liquid stable clinical reference materials for both total and direct Bilirubin assays.
Engineers have developed a prototype of such a wearable device that can continuously monitor glucose, alcohol, and lactate levels.
Avista Capital Partners, a private equity firm focused on healthcare, closed on the sale of pathology laboratory Inform Diagnostics to Fulgent Genetics.
A 384-well option is now available for Thermo Fisher Scientific’s Applied Biosystems QuantStudio 7 Pro Dx Real-Time PCR System.